Lenvatinib
Active pharmaceutical substance formulated in Jan Aushadhi generic products for Oncology & Critical Care treatment.
🧴 Clinical Application
Thyroid cancer: 24 mg once daily. HCC: 8 mg (<60 kg) or 12 mg (>=60 kg) once daily with or without food with water. Swallow capsules whole.
⚠️ Side Effects
Common: Severe hypertension, diarrhea, fatigue, decreased appetite, weight loss, arthralgia, proteinuria, palmar-plantar erythrodysesthesia. Rare/Severe: Cardiac dysfunction, arterial thromboembolism, hepatotoxicity, renal failure, and posterior reversible encephalopathy syndrome.
🛡️ Safety Warnings
Control blood pressure prior to therapy; monitor BP weekly during the first 2 months and monthly thereafter. Perform routine urinalysis to check for proteinuria. Withhold lenvatinib prior to major surgical procedures due to impaired wound healing.
Jan Aushadhi Products containing Lenvatinib
Found 1 generic formulation(s) containing this active ingredient.
Brand Equivalents & Price Comparison
Compare Jan Aushadhi generic prices against popular commercial brands for Lenvatinib.
| Generic Formulation | Pack Size | Jan Aushadhi Price | Commercial Brand Equivalents | Avg. Commercial Price | Savings |
|---|---|---|---|---|---|
| Lenvatinib Capsules 4Mg | 10's bottle | ₹530.00 | LENVAT, LENVATOL, LENVENIB | ₹1100.16 | 52% Save |
Frequently Asked Questions (FAQ)
Get answers to common queries about Lenvatinib generics.